We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

63 hedge funds and large institutions have $96.2M invested in Provention Bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

33% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $1.38M

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

5% more funds holding

Funds holding: 60 → 63 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

27% less capital invested

Capital invested by funds: $131M → $96.2M (-$34.9M)

Holders
63
Holders Change
+3
Holders Change %
+5%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
20
Reduced
17
Closed
16
Calls
$1.83M
Puts
$1.38M
Net Calls
+$453K
Net Calls Change
-$1.5M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$6.99M
2
Invesco
Invesco
Georgia
+$4.57M
3
OM
Opaleye Management
Massachusetts
+$2.14M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.04M
5
EGI
EAM Global Investors
California
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.46M
2
ECM
ExodusPoint Capital Management
New York
-$1.33M
3
CS
Credit Suisse
Switzerland
-$1.31M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$1.05M
5
LCM
Laurion Capital Management
New York
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
WCA
51
Windsor Creek Advisors
Vermont
$129K +$180K +14,000 New
Citigroup
52
Citigroup
New York
$120K +$121K +9,408 +258%
Victory Capital Management
53
Victory Capital Management
Texas
$118K +$166K +12,874 New
Osaic Holdings
54
Osaic Holdings
Arizona
$111K +$155K +12,050 New
BWP
55
Baldwin Wealth Partners
Massachusetts
$83K +$116K +9,000 New
FAM
56
Fred Alger Management
New York
$64K +$90.2K +7,000 New
Simplex Trading
57
Simplex Trading
Illinois
$62K -$412 -32 -0.5%
FC
58
FORA Capital
Florida
$32K +$44.6K +3,463 New
US Bancorp
59
US Bancorp
Minnesota
$28K – – –
CG
60
Cutler Group
California
$11K +$16.8K +1,300 New
TWA
61
TCI Wealth Advisors
Arizona
$7K -$2.58K -200 -20%
Royal Bank of Canada
62
Royal Bank of Canada
Ontario, Canada
$5K -$5.8K -450 -47%
PNC Financial Services Group
63
PNC Financial Services Group
Pennsylvania
$2K +$2.58K +200 New
LCM
64
Laurion Capital Management
New York
– -$1.02M -68,340 Closed
Stifel Financial
65
Stifel Financial
Missouri
– -$823K -55,200 Closed
HP
66
Hound Partners
New York
– -$522K -35,000 Closed
SCP
67
Silverleafe Capital Partners
Tennessee
– -$298K -20,000 Closed
OGC
68
One68 Global Capital
New York
– -$273K -18,331 Closed
OAM
69
Oxford Asset Management
United Kingdom
– -$242K -16,274 Closed
6CM
70
683 Capital Management
New York
– -$233K -15,608 Closed
MA
71
Mutual Advisors
Nebraska
– -$224K -15,000 Closed
AGM
72
Alpine Global Management
New York
– -$217K -14,535 Closed
BRWA
73
B. Riley Wealth Advisors
Florida
– -$194K -13,000 Closed
TRCT
74
Tower Research Capital (TRC)
New York
– -$109K -7,301 Closed
QT
75
Quantbot Technologies
New York
– -$24K -1,621 Closed
1 2
3
4

PRVB Hedge Fund Activity: Q1 2020 in Review

63 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q1 2020, worth a combined $96.2M — down 27% from $131M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new PRVB positions and 16 closed out — a net gain of 6 holders — while 20 added to existing stakes and 17 trimmed.

The largest buyer was Millennium Management, adding an estimated $6.99M. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $1.46M.

  • 63 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q1 2020, up from 60 in Q4 2019.
  • Funds reported $96.2M of Provention Bio, Inc. Common Stock stock for Q1 2020, down 27% quarter-over-quarter.
  • 22 funds opened new Provention Bio, Inc. Common Stock positions in Q1 2020 and 16 closed out, a net change of +6 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q1 2020 was Millennium Management, an estimated $6.99M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q1 2020 was Qube Research & Technologies (QRT), an estimated $1.46M sold.

Based on aggregated 13F filings for Q1 2020.